Commonoral anti-sugar drug "retail exclusive" large packaging on the market, help to improve patient compliance.

"Pharmaceutical Network Industry Dynamics" Diabetes is a common chronic disease, long-term high blood sugar may cause the eyes, heart, blood vessels, nerves and other organ tissue chronic damage and dysfunctionWith the aging of our country, people's work pressure increases, the prevalence of diabetes is also increasingAccording to new epidemiological data released by the, the prevalence of diabetes in adults aged 18 and over in Chinese mainland has reached 12.8%, according to estimates that the number of adults with diabetes in China has reached 129.8 millionit is understood that the management of chronic disease "work in the daily", for diabetics, the need to use drugs can effectively control sugar under the premise of time lying according to the amount, regular medication, in order to improve the compliance of medicationbecause of the majority of diabetic patients to middle-aged and elderly, many patients because of the purchase is not convenient, or because of poor medication irregular, in order to help patients do a good job of diabetes management, recently, Sanofi and the chain of pharmacies launched the commonly used oral sugar-lowering drug Amoli (Gremedium tablets) "retail exclusive" large packaging, from the original 15 "upgrade" to 60 tabletsthis also means that in the future, in Jiangsu, Zhejiang, Hebei, Guangdong, Liaoning and other areas of diabetes, just by virtue of the corresponding prescription, you can go to the pharmacy to buy medicine, a allocation of 1-2 monthsdata show that Gremetre tablets are the third generation of sulfonyl diazepam oral hypoglycemic drugs, insulin progenitors for sulfonyl, and can be used for oral medium- and long-acting sulfonyl anti-diabetic drugs, which is a national health insurance drugin addition, Gremeytablet tablets only need to be taken once a day, not affected by the meal, with a high convenience, but also conducive to improve patients' drug complianceand behind the launch of the Grammys" "retail-only" large package, you can also see that the chain of pharmacies is upgrading its functions, playing an increasingly important role in promoting the management of chronic diseasesat present, the state is vigorously promoting the concept of care from "cure-centered" to "health-centered"in this context, the chain of pharmacies as an effective complement to the function of the hospital, will become to promote the realization of slow disease management services closed-loop important rolein the industry, diabetes treatment is a long-term and constantly adjusted with the progress of the disease integrated management processin the existing medical resources, the need for chain pharmacies and other resources to play a greater role, to assume more slow-motion management, with hospitals, communities and other complementary advantages, to help diabetics to play a good job of controlling blood sugar this "enduring war."in addition to retail services, the chain of pharmacies also has health counseling, drug guidance, disease science, blood pressure testing and other functions, can be said to be diabetics around the "health butler."today, pharmacies are launching "pharmacy-only version" of large packaging, not only can help patients with longer dosages, but also to further improve patients' drug compliance, and effectively for its daily disease management "reduced negative."led by Sanofi, the French pharmaceutical giant, Sanofi launched a cost-effective "pharmacy custom version" of large packaging action, in the industry seems to be in line with the country's promotion of this year's "long prescription" service - chronically ill patients can be issued more than 2 weeks or more of the drug prescriptionin addition to Thegrammy tablets, Sanofi also launched Ambono and Porivi two cardiovascular drugs "pharmacy custom version" large packaging, from the original 7 capsule "upgrade" to 28 capsules, and also enjoy medical insurance reimbursement, patients only need to rely on the corresponding prescription in the fixed-point health insurance pharmacy can buy a one-time amount of about one month, reduce the number of back and forth to buy drugs, greatly improve the patient's compliance.